DV
Dividend Vision

PALI — Palisade Bio Inc

Palisade Bio Inc (PALI)

Its deepest 1-year drawdown was 40.4%.

Based on the available data, this equity fund focuses on stock holdings within the biotechnology sector. The fund's complete characteristics—including its specific investment strategy, expense ratio, yield profile, and distribution frequency—are not currently available in the dataset. The limited information suggests this product may appeal to investors with exposure interests in the biotech industry, though prospective investors should consult official fund documentation for comprehensive details on holdings, costs, and income distribution policies.

PALI key facts

Asset type
Stock
Asset class
Equity
Inception date
12/20/2006
Last close
$2.14
Market cap
$331,919,168
Average volume
1605000.0
Payment date
07/18/2019
Beta
1.512
Payout ratio
0.0
P/E ratio
15.9167
Forward P/E
0.0
EPS
$0.12